Meeting of the National Vaccine Advisory Committee, 29568-29569 [2016-11243]

Download as PDF asabaliauskas on DSK3SPTVN1PROD with NOTICES 29568 Federal Register / Vol. 81, No. 92 / Thursday, May 12, 2016 / Notices limited to two pages and submitted through https://www.regulations.gov enter CDC–2016–0036 in the search field and click ‘‘Search’’ by May 29, 2016. Efforts will be made to provide the two-page written comments received by the deadline above to the committee members before the meeting. Comments in excess of two pages will be made publicly available at https:// www.regulations.gov (enter CDC–2016– 0036 in the search field and click ‘‘Search’’). Policy on Redaction of Committee Meeting Transcripts (Public Comment): Transcripts will be prepared and posted to https://www.regulations.gov (enter CDC–2016–0036 in the search field and click ‘‘Search’’) within 60 days after the meeting. If a person making a comment gives his or her name, no attempt will be made to redact that name. NIOSH will take reasonable steps to ensure that individuals making public comments are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include a statement read at the start of the meeting stating that transcripts will be posted and names of speakers will not be redacted. If individuals in making a statement reveal personal information (e.g., medical information) about themselves, that information will not usually be redacted. The CDC Freedom of Information Act coordinator will, however, review such revelations in accordance with the Freedom of Information Act and, if deemed appropriate, will redact such information. Disclosures of information concerning third party medical information will be redacted. Contact Person for More Information: Paul J. Middendorf, Ph.D., Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail Stop E–20, Atlanta, Georgia 30345, telephone 1 (888) 982–4748; email: wtc-stac@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–11141 Filed 5–11–16; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:02 May 11, 2016 Jkt 238001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting June 7–8, 2016. The meeting is open to the public. However, pre-registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at https://www.hhs.gov/nvpo/ nvac/meetings/upcomingmeetings. Participants may also register by emailing nvpo@hhs.gov or by calling (202) 690–5566 and providing their name, organization, and email address. DATES: The meeting will be held on June 7–8, 2016. The meeting times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/ nvac/meetings/upcomingmeetings as soon as they become available. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, the Great Hall, 200 Independence Avenue SW., Washington, DC 20201. The meeting can also be accessed through a live webcast the day of the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; email: nvpo@ hhs.gov. SUMMARY: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters SUPPLEMENTARY INFORMATION: PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The June 2016 NVAC meeting will continue important discussions on addressing the barriers and scientific challenges to the development of new and improved vaccines, with a presentation from the NVAC Maternal Immunization Working Group of their draft recommendations for overcoming barriers to research and development of vaccines for use in pregnant women. The NVAC will host a comprehensive discussion on the financial costs and perceived barriers to providing immunization services across the lifespan. Committee discussions will also include an update on immunization priorities at the local level, efforts to improve immunization coverage among adults and adolescents, and findings from a midcourse review of the 2010 National Vaccine Plan on the areas of greatest opportunity for strengthening the immunization system going forward. Please note that agenda items are subject to change as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac. Public attendance at the meeting is limited to the available space. Individuals who plan to attend in person and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at https://www.hhs.gov/ nvpo/nvac/meetings/ upcomingmeetings. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the National Vaccine Program Office (nvpo@hhs.gov) at least five business days prior to the meeting. E:\FR\FM\12MYN1.SGM 12MYN1 Federal Register / Vol. 81, No. 92 / Thursday, May 12, 2016 / Notices Dated: May 3, 2016. Bruce Gellin, Executive Secretary, National Vaccine Advisory Committee, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. 2016–11243 Filed 5–11–16; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Re-Establishment of the Physical Activity Guidelines Advisory Committee and the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services. ACTION: Notice. asabaliauskas on DSK3SPTVN1PROD with NOTICES AGENCY: Authority: Re-establishment of the Physical Activity Guidelines Advisory Committee and the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives is authorized under 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended. The Committees will be governed by provisions of the Federal Advisory Committee Act, Public Law 92–463, as amended (5 U.S.C. App.), which sets forth standards for the formation and use of advisory committees. SUMMARY: The U.S. Department of Health and Human Services (HHS) announces re-establishment of the Physical Activity Guidelines Advisory Committee and the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives. The new titles for the Committees are the 2018 Physical Activity Guidelines Advisory Committee and the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, respectively. The 2018 Physical Activity Guidelines Advisory Committee and the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives have been established as discretionary federal advisory committees. Both committees have been established to perform single, timelimited tasks that will assist with furthering the mission of the HHS. FOR FURTHER INFORMATION CONTACT: 2018 Physical Activity Guidelines Advisory Committee: Richard D. Olson, MD, MPH; Designated Federal Officer or VerDate Sep<11>2014 17:02 May 11, 2016 Jkt 238001 LT Katrina L. Piercy, Ph.D., RD, ACSM– CEP, Alternate DFO; Office of Disease Prevention and Health Promotion, OASH/DHHS; 1101 Wootton Parkway, Suite LL100 Tower Building; Rockville, MD 20852; Telephone: (240) 453–8280; Fax: (240) 453–8281. Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030: Emmeline Ochiai, Designated Federal Officer or Carter Blakey, Alternate DFO; Office of Disease Prevention and Health Promotion, OASH/DHHS; 1101 Wootton Parkway; Suite LL 100 Tower Building; Rockville, MD 20852; Telephone: (240) 453–8280; Fax: (240) 453–8281. Additional information about the 2018 Physical Activity Guidelines Advisory Committee can be found at https:// health.gov/paguidelines. Additional information about the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives can be found at https:// www.healthypeople.gov. On April 26, 2016, the Secretary approved for the Physical Activity Guidelines Advisory Committee and the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives to be re-established. Both committees have been re-established to accomplish single, time-limited tasks. The Physical Activity Guidelines Advisory Committee was first established in February 2007 to assist the Department in development of the first edition of the Physical Activity Guidelines for Americans (PAG). The Department plans to develop a second edition of the PAG, and it was recommended that the same process be used to develop this document. The new committee will examine the current edition of the PAG, take into consideration new scientific evidence and current resource documents, and then develop a scientific advisory report that will be submitted to the Secretary. The title for the new committee is the 2018 Physical Activity Guidelines Advisory Committee (2018 PAGAC; the Committee). Objectives and Scope of Activities. The 2018 PAGAC will provide independent advice and recommendations based on current scientific evidence for use by the federal government in the development of the second edition of the PAG. The PAG provides a foundation for federal recommendations and education for physical activity programs for Americans, including those at risk for chronic disease. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 29569 Description of Duties. The work of the 2018 PAGAC is solely advisory in nature. The Committee will be established for the single, time-limited task of reviewing the current edition of the PAG and conducting an evidencebased systematic literature review of physical activity and health for use in developing physical activity recommendations to promote health and reduce chronic disease risk. Membership and Designation. The 2018 PAGAC will be composed of 11 to 17 members. One or more members will be selected to serve as the Chair, Vice Chair, and/or Co-Chairs. The Committee will consist of respected published experts in designated fields and specific specialty areas. Individuals appointed to serve on the Committee will have demonstrated expert knowledge of current science in the field of human physical activity and health promotion or the prevention of chronic disease. Members will be appointed to the Committee by the Secretary of HHS and invited to serve for the duration of the Committee. All appointed members of the Committee will be classified as special government employees (SGEs). Administrative Management and Support. The 2018 PAGAC will provide advice to the Secretary of Health and Human Services, through the Assistant Secretary for Health (ASH). The Committee will provide a report to the Secretary, outlining their recommendations and rationale for the second edition of the PAG. Management and support services for the Committee will be provided within the Office of the Assistant Secretary for Health (OASH) by the Office of Disease Prevention and Health Promotion (ODPHP). The ODPHP is a program staff office within OASH; OASH is a staff division in the HHS Office of the Secretary. ODPHP will collaborate with the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the OASH program staff office for the President’s Council on Fitness, Sports, and Nutrition (PCFSN). The ASH will appoint seven Co-Executive Secretaries to support the Committee, two each from the ODPHP, CDC, and NIH, and one from the OASH staff office for the PCFSN. The two ODPHP Co-Executive Secretaries will be appointed to serve as the DFO and Alternate DFO for the Committee. The Department established the Healthy People initiative in 1979. The initiative was established to develop a framework for improving the health of all people in the United States. Healthy People provides evidence-based, ten- E:\FR\FM\12MYN1.SGM 12MYN1

Agencies

[Federal Register Volume 81, Number 92 (Thursday, May 12, 2016)]
[Notices]
[Pages 29568-29569]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11243]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that 
the National Vaccine Advisory Committee (NVAC) will hold a meeting June 
7-8, 2016. The meeting is open to the public. However, pre-registration 
is required for both public attendance and public comment. Individuals 
who wish to attend the meeting and/or participate in the public comment 
session should register at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings. Participants may also register by emailing 
nvpo@hhs.gov or by calling (202) 690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on June 7-8, 2016. The meeting times 
and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings as soon as they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION:  Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The June 2016 NVAC meeting will continue important discussions on 
addressing the barriers and scientific challenges to the development of 
new and improved vaccines, with a presentation from the NVAC Maternal 
Immunization Working Group of their draft recommendations for 
overcoming barriers to research and development of vaccines for use in 
pregnant women. The NVAC will host a comprehensive discussion on the 
financial costs and perceived barriers to providing immunization 
services across the lifespan. Committee discussions will also include 
an update on immunization priorities at the local level, efforts to 
improve immunization coverage among adults and adolescents, and 
findings from a midcourse review of the 2010 National Vaccine Plan on 
the areas of greatest opportunity for strengthening the immunization 
system going forward. Please note that agenda items are subject to 
change as priorities dictate. Information on the final meeting agenda 
will be posted prior to the meeting on the NVAC Web site: https://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the National Vaccine Program Office at 
the address/phone listed above at least one week prior to the meeting. 
For those unable to attend in person, a live webcast will be available. 
More information on registration and accessing the webcast can be found 
at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office (nvpo@hhs.gov) at least five 
business days prior to the meeting.


[[Page 29569]]


    Dated: May 3, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2016-11243 Filed 5-11-16; 8:45 am]
 BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.